日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Survival of patients with colorectal or pancreatic cancer who received UGT1A1 genotype-guided dosing of irinotecan in the Netherlands (2017-2024): a retrospective, multicentre cohort study

荷兰(2017-2024 年)接受 UGT1A1 基因型指导的伊立替康给药治疗的结直肠癌或胰腺癌患者的生存情况:一项回顾性多中心队列研究

Peeters, Sofía L J; Heersche, Niels; Böhm, Doortje; Böhringer, Stefan; Guiljam, Roselien; Hulshof, Emma C; de Man, Femke M; de With, Mirjam; Joosse, Marije; Oomens, Gysella; Wu, Qiong-Yi; Osman, Aisha; Bins, Sander; van Hellemond, Irene E G; Haberkorn, Brigitte C M; Verschoor, Arjan J; Wumkes, Miriam L; van Schaik, Ron H N; Thijs, Anna M; Gelderblom, Hans; Guchelaar, Henk-Jan; Mathijssen, Ron H J; Deenen, Maarten J

Health-related Quality of Life in Localized and Metastatic Renal Cell Carcinoma: Insights from Patient-reported Outcome Measures

局部和转移性肾细胞癌患者的健康相关生活质量:来自患者报告结局指标的启示

Duijn, Matthijs; Yildirim, Hilin; van den Hurk, Corina; Postema, Arnoud W; Aarts, Maureen J B; Aben, Katja; van Oijen, Martijn G H; Bins, Adriaan D; Zondervan, Patricia J

Trends in treatment and survival of older vs younger patients with renal cancer between 2011 and 2022

2011年至2022年间老年肾癌患者与年轻肾癌患者的治疗和生存趋势

Yildirim, Hilin; Schuurman, Melinda S; van Melick, Harm H E; Bins, Adriaan D; Zondervan, Patricia J; Aben, Katja K H

Correction: Impact of chemoradiotherapy for bladder cancer on pre-existing hydronephrosis and development of new hydronephrosis

更正:膀胱癌放化疗对既有肾积水和新发肾积水的影响

Remmelink, Marinka J; El Awadly, Nader; Arbeel-Weening, Berber; Nadorp, Sven; Leter, Maicle R; Oddens, Jorg R; Brück, Katharina; Nieuwenhuijzen, Jakko A; Bins, Adriaan D

Cranial Defect Reconstruction With Custom 3D-Printed Hydroxyapatite Scaffolds Augmented With rhBMP-2 or Dipyridamole in a Nonhuman Primate Model

在非人灵长类动物模型中,使用定制的3D打印羟基磷灰石支架联合rhBMP-2或双嘧达莫进行颅骨缺损重建

Bins, Griffin P; Burkart, Heather A; Molair, William; Kogan, Samuel; Massary, Dominic A; Pereira, Angel Cabrera; Aksu, Adem; Reinauer, Frank; Couture, Daniel A; Witek, Lukasz; Runyan, Christopher M

Bioequivalence of alternative pembrolizumab dosing regimens: current practice and future perspectives

帕博利珠单抗不同给药方案的生物等效性:现状与展望

Malmberg, Ruben; Agema, Bram C; Hofman, Maaike M; Oosterveld, Stefani; Bins, Sander; Dumoulin, Daphne W; Joosse, Arjen; Aerts, Joachim G J V; Debets, Reno; Koch, Birgit C P; van der Veldt, Astrid A M; van Leeuwen, Roelof W F; Mathijssen, Ron H J

Uncovering the Risk: Incidence of Upper Tract Urothelial Carcinoma Following Renal Transplantation in the Netherlands

揭示风险:荷兰肾移植术后上尿路尿路上皮癌的发生率

Figaroa, Orlane J A; Bek, J; Savci-Heijink, C D; Idu, M M; Bins, A D; van Moorselaar, R J A; Baard, J

Immunotherapy in metastatic renal cell carcinoma: Insights from a Dutch nationwide cohort

转移性肾细胞癌的免疫疗法:来自荷兰全国队列研究的启示

Yildirim, Hilin; Richters, Anke; Bins, Adriaan D; Postema, Arnoud W; Aarts, Maureen J B; van Oijen, Martijn G H; Zondervan, Patricia J; Aben, Katja K H

Digital solutions, real-world challenges: lessons from mHealth trials in oncology

数字化解决方案,现实世界的挑战:来自肿瘤学移动医疗试验的经验教训

Stuijt, Dominique G; Radanovic, Igor; Exadaktylos, Vasileios; Kapiteijn, Ellen; van der Hulle, Tom; Oddens, Jorg R; van Gennep, Erik; Daamen, Lois A; Bak, Marieke A R; Ploem, M Corrette; van Oijen, Martijn G H; Bins, Adriaan D; Bosch, Jacobus J

Impact of chemoradiotherapy for bladder cancer on pre-existing hydronephrosis and development of new hydronephrosis

膀胱癌放化疗对既有肾积水及新发肾积水的影响

Remmelink, Marinka J; Awadly, Nader El; Arbeel-Weening, Berber; Nadorp, Sven; Leter, Maicle R; Oddens, Jorg R; Brück, Katharina; Nieuwenhuijzen, Jakko A; Bins, Adriaan D